Results 21 to 30 of about 21,316 (178)

Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study

open access: yesSwiss Medical Weekly, 2023
BACKGROUND: Carriers of germline pathogenic variants of the BRCA1 gene (gBRCA1) tend to have a higher incidence of haematological toxicity upon exposure to chemotherapy.
Noémie Lang   +10 more
doaj   +1 more source

A Neonatal Agranulocytosis [PDF]

open access: yesClinical Chemistry, 2014
A 42-year-old gravida 5 para 3 woman delivered a male newborn at 36 weeks of gestation. She had no significant medical problems and her previous pregnancies led to healthy newborns. The current pregnancy was uneventful and the baby appeared healthy (body weight, 3190 g; Apgar score, 8/10/10). On the second day of life jaundice appeared.
Hervé, Delacour   +5 more
openaire   +2 more sources

Agranulocytosis in systemic lupus erythematosus: A case report

open access: yesClinical Case Reports, 2022
Agranulocytosis is a rare acute condition characterized by severe a 
Olfa Frikha   +6 more
doaj   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Late onset clozapine induced agranulocytosis

open access: yesIndian Journal of Psychological Medicine, 2014
Agranulocytosis is defined as an absolute neutrophil count less than 100/mm 3 in association with infectious disease. The risk of agranulocytosis is 0.38% of all clozapine treated cases and there is a relatively lesser incidence in Indian population. The
Rajmohan Velayudhan, Sushil Kakkan
doaj   +1 more source

Drug-Induced Neutropenia and Agranulocytosis

open access: yesБезопасность и риск фармакотерапии, 2020
Drug-induced neutropenia and agranulocytosis are serious and potentially life-threatening complications of pharmacotherapy. The aim of the review was to systematise and analyse scientific literature on the prevalence, risk factors, pathogenesis, clinical
O. D. Ostroumova   +3 more
doaj   +1 more source

Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case

open access: yesCase Reports in Endocrinology, 2015
Agranulocytosis is a rare and critical adverse effect of antithyroid drugs (ATD). The occurrence of agranulocytosis in continuous ATD treatment patients is well known; however, a case of ATD agranulocytosis occurring following the discontinuation of ...
Rıfkı Üçler   +7 more
doaj   +1 more source

Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous

open access: yesFrontiers in Pharmacology, 2021
Drug-induced agranulocytosis is a life-threatening side effect that usually manifests as a severe form of neutropenia associated with fever or signs of sepsis.
Bernd Rattay, Ralf A. Benndorf
doaj   +1 more source

Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2017
Antithyroid drugs can be a rare cause of agranulocytosis (0.5% of treated patients). Suspension of these drugs is mandatory in these patients and may result in worsening hyperthyroidism.
Anna Candoni
doaj   +1 more source

Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia

open access: yesJournal of the Formosan Medical Association, 2019
Background/Purpose: Physicians' and dentists' knowledge of levamisole-induced agranulocytosis or pancytopenia remains incomplete. This study aimed to evaluate the treatment effectiveness of levamisole plus prednisolone on oral lichen planus (OLP ...
Shin-Yu Lu, Tzu-Fan Chang, Chih-Jen Lin
doaj   +1 more source

Home - About - Disclaimer - Privacy